Susquehanna International Group, LLP Mersana Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.23 - $2.25 $38,622 - $70,650	31,400 Added 203.9%	46,800 $88,000
Q2 2024 Aug 15, 2024	SELL	$2.0 - $4.45 $241,400 - $537,115	-120,700 Reduced 88.68%	15,400 $30,000
Q1 2024 May 07, 2024	BUY	$2.16 - $5.94 $293,976 - $808,434	136,100 New	136,100 $609,000
Q2 2023 Aug 11, 2023	BUY	$3.08 - $9.55 $277,200 - $859,500	90,000 Added 286.62%	121,400 $399,000
Q1 2023 May 16, 2023	BUY	$4.0 - $7.02 $125,600 - $220,428	31,400 New	31,400 $129,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $215M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.